1st TAVR Device Receives European Approval to Treat Intermediate Risk Patients
from Diagnostic and Interventional Cardiology
Medtronic announced CE (Conformité Européenne) mark market clearnace for the self-expanding, recapturable and repositionable CoreValve Evolut R System to treat aortic stenosis patients who are at intermediate risk for open-heart surgery. The Evolut R System is the first transcatheter aortic valve replacement device to obtain this expanded indication in Europe.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063